Skip to main content
Full access
Letter to the Editor
Published Online: 1 December 2001

Drs. Halpern and Pope Reply

To the Editor: We thank Dr. Bogenschutz for supporting our view that the Internet provides a novel window into assessing current and emerging patterns of illicit drug use. As mentioned in our article, no web-based search will yield the same results over time; hence, Dr. Bogenschutz’s web search yielded interesting further findings since our survey was conducted in December of 1998. Many of the additional hallucinogens and nonhallucinogens that he mentions were noted by us as well but were edited from our final report for brevity.
The dearth of reports in the medical literature about problems with hallucinogens is perhaps unsurprising, given their long history of apparently safe ritual use in many traditional societies. For example, of the 982,856 drug-related emergency room visits reported in 1998, fewer than 5,000 involved LSD, compared to 172,000 related to cocaine (1). However, use of hallucinogens may continue in the United States and elsewhere in larger numbers than we might think. As one authority has commented, “Large numbers of people, mostly young, male and with high intelligence and creative ability are taking hallucinatory drugs without the medical profession being much aware of it. It is only when something goes wrong that the doctor is involved” (2).
We agree with Dr. Bogenschutz that much of the information posted at Internet drug sites is “quite accurate.” Of greater concern is how inadequate our scientific knowledge of these compounds remains. The bulk of the medical literature on hallucinogens is out of date and compromised by multiple methodological limitations. The Internet reveals that there are literally hundreds of drugs with hallucinogenic properties being ingested by humans, most of which have never been medically evaluated for dose range, effect, risk, or abuse liability. Can American psychiatric research continue to remain idle in this area while this “hidden” and ever-expanding pharmacopoeia is disseminated only across public forums like the Internet?

Reference

1.
Office of Applied Studies, Substance Abuse and Mental Health Services Administration: Year-End 1998 Emergency Department Data From the Drug Abuse Warning Network. Rockville, Md, National Clearinghouse for Alcohol and Drug Information, 2000
2.
Sandison RA: The hallucinogenic drugs. Practitioner 1968; 200:244-250

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 2095
PubMed: 11729053

History

Published online: 1 December 2001
Published in print: December 2001

Authors

Affiliations

HARRISON G. POPE, Jr., M.D.
Belmont, Mass.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share